Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Company profile
Website
CEO
Geoffrey Straub Martha
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
SEC CIK
Corporate docs
IRS number
410793183
Latest filings (excl ownership)
424B5
Prospectus supplement for primary offering
24 Mar 23
FWP
Free writing prospectus
23 Mar 23
424B3
Prospectus supplement
23 Mar 23
25-NSE
Exchange delisting
15 Mar 23
25-NSE
Exchange delisting
10 Mar 23
S-3ASR
Automatic shelf registration
3 Mar 23
25-NSE
Exchange delisting
2 Dec 22
CERT
Certification of approval for exchange listing
21 Sep 22
8-A12B
Registration of securities on exchange
21 Sep 22
424B5
Prospectus supplement for primary offering
16 Sep 22
Latest ownership filings
4
Inspire Medical Systems, Inc.
9 May 18
3
Inspire Medical Systems, Inc.
2 May 18
SC 13G
GI DYNAMICS, INC.
17 Feb 15
SC 13G
Medtronic Inc
12 Feb 15
SC 13G/A
Medtronic Inc
11 Feb 15
SC 13G/A
Medtronic Inc
30 Jan 15
SC 13G
Intersect ENT, Inc.
23 Jan 15
11-K
Annual report of employee stock purchases
21 Oct 14
11-K
Annual report of employee stock purchases
21 Oct 14
SC 13G/A
Medtronic Inc
14 Feb 14
Institutional ownership, Q2 2023
0.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 15 |
Opened positions | 2 |
Closed positions | 2 |
Increased positions | 3 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 15.87 bn |
Total shares | 2.43 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Troy Asset Management | 1.47 mm | $129.79 mm |
Mn Services Vermogensbeheer B.V. | 638.40 k | $56.24 mm |
Cyrus J. Lawrence | 94.88 k | $8.36 mm |
Cohen Klingenstein | 83.10 k | $7.32 bn |
Ironwood Investment Counsel | 60.56 k | $5.34 bn |
Columbia Asset Management | 29.80 k | $2.63 mm |
Beacon Financial | 16.98 k | $1.47 mm |
Kades & Cheifetz | 8.35 k | $735.55 mm |
West Oak Capital | 6.99 k | $615.38 mm |
Penobscot Investment Management | 6.92 k | $609.21 mm |